Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis

Authors:

Abstract
No abstract available
Funding Information
  • Sanofi
  • Biogen
  • Teva Pharmaceutical Industries
  • Merck KGaA
  • Bayer HealthCare
  • Novartis
  • Bayer Schering

This publication has 17 references indexed in Scilit: